Biodesix (BDSX) PT Lowered to $2 at TD Cowen; '1Q Miss & Guide Down as Sales Force Headcount Lags'
Tweet Send to a Friend
TD Cowen analyst Dan Brennan lowered the price target on Biodesix (NASDAQ: BDSX) to $2.00 (from $3.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
